Randomized Trial of Marine n-3 Polyunsaturated Fatty Acids for the Prevention of Cerebral Small Vessel Disease and Inflammation in Aging (PUFA Trial): Rationale, Design and Baseline Results
暂无分享,去创建一个
David L. Lahna | J. Kaye | H. Dodge | J. Quinn | D. Howieson | L. Silbert | C. Murchison | G. Bowman | L. Shinto | D. Lahna | Kirsten Hagen
[1] Prevention Study , 2020, Definitions.
[2] Deepak L. Bhatt,et al. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia , 2019, The New England journal of medicine.
[3] J. Manson,et al. Marine n‐3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer , 2019, The New England journal of medicine.
[4] N. Bazan. Docosanoids and elovanoids from omega-3 fatty acids are pro-homeostatic modulators of inflammatory responses, cell damage and neuroprotection. , 2018, Molecular aspects of medicine.
[5] D. Norris,et al. Memory decline in elderly with cerebral small vessel disease explained by temporal interactions between white matter hyperintensities and hippocampal atrophy , 2018, Hippocampus.
[6] J. Wojcik,et al. Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults , 2018, Alzheimer's & Dementia.
[7] E. Mormino,et al. APOE genotype and early β-amyloid accumulation in older adults without dementia , 2017, Neurology.
[8] Erick J. Paul,et al. Predictors of Memory in Healthy Aging: Polyunsaturated Fatty Acid Balance and Fornix White Matter Integrity , 2017, Aging and disease.
[9] S. Lehéricy,et al. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial , 2017, The Lancet Neurology.
[10] A. Green,et al. Plasma eicosapentaenoic acid is negatively associated with all-cause mortality among men and women in a population-based prospective study. , 2016, Nutrition research.
[11] Blair H. Smith,et al. GWAS for executive function and processing speed suggests involvement of the CADM2 gene , 2016, Molecular Psychiatry.
[12] David L. Lahna,et al. Characterizing the white matter hyperintensity penumbra with cerebral blood flow measures , 2015, NeuroImage: Clinical.
[13] Lucia Kerti,et al. Long-chain omega-3 fatty acids improve brain function and structure in older adults. , 2014, Cerebral cortex.
[14] Charles N. Serhan,et al. Pro-resolving lipid mediators are leads for resolution physiology , 2014, Nature.
[15] Hiroko H. Dodge,et al. Plasma omega-3 PUFA and white matter mediated executive decline in older adults , 2013, Front. Aging Neurosci..
[16] D. Mozaffarian,et al. Circulating Omega‐3 Polyunsaturated Fatty Acids and Subclinical Brain Abnormalities on MRI in Older Adults: The Cardiovascular Health Study , 2013, Journal of the American Heart Association.
[17] D. Salmon,et al. The Multilingual Naming Test in Alzheimer's Disease: Clues to the Origin of Naming Impairments , 2013, Journal of the International Neuropsychological Society.
[18] W. Harris,et al. Red blood cell omega-3 fatty acid levels and neurocognitive performance in deployed U.S. Servicemembers , 2013, Nutritional neuroscience.
[19] D. Holtzman,et al. Apolipoprotein E, Especially Apolipoprotein E4, Increases the Oligomerization of Amyloid β Peptide , 2012, The Journal of Neuroscience.
[20] Cécile Proust-Lima,et al. Plasma long-chain omega-3 fatty acids and atrophy of the medial temporal lobe , 2012, Neurology.
[21] Steven Hou,et al. Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-β. , 2012, Brain : a journal of neurology.
[22] C. Annweiler,et al. Nutrient Biomarker Patterns, Cognitive Function, and Mri Measures of Brain Aging , 2012, Neurology.
[23] Jie Cao,et al. Effect of omega-3 fatty acids supplementation on endothelial function: a meta-analysis of randomized controlled trials. , 2012, Atherosclerosis.
[24] C. DeCarli,et al. Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging , 2012, Neurology.
[25] C. Moy,et al. Vascular risk factors and cognitive impairment in a stroke-free cohort , 2011, Neurology.
[26] M. Weiner,et al. Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample , 2011, Neurology.
[27] S. Black,et al. Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.
[28] K. Yaffe,et al. The projected effect of risk factor reduction on Alzheimer's disease prevalence , 2011, The Lancet Neurology.
[29] J. Kramer,et al. Mild cognitive impairment, dementia, and their subtypes in oldest old women. , 2011, Archives of neurology.
[30] H. Dodge,et al. Risk of Alzheimer's disease incidence attributable to vascular disease in the population , 2011, Alzheimer's & Dementia.
[31] Barry Oken,et al. Reliability and Validity of Food Frequency Questionnaire and Nutrient Biomarkers in Elders With and Without Mild Cognitive Impairment , 2011, Alzheimer disease and associated disorders.
[32] N. Venketasubramanian,et al. The Montreal Cognitive Assessment (MoCA) is superior to the Mini-Mental State Examination (MMSE) for the detection of vascular cognitive impairment after acute stroke , 2010, Journal of the Neurological Sciences.
[33] K. Jellinger,et al. Is there pure vascular dementia in old age? , 2010, Journal of the Neurological Sciences.
[34] Michael Weiner,et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. , 2010, JAMA.
[35] P. Calder,et al. Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability. , 2010, Atherosclerosis.
[36] D. Mozaffarian,et al. Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal Through 2020 and Beyond , 2010, Circulation.
[37] D. Ding,et al. Plasma level of sICAM-1 is associated with the extent of white matter lesion among asymptomatic elderly subjects , 2009, Clinical Neurology and Neurosurgery.
[38] L. D. de Groot,et al. Fish-oil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells. , 2009, The American journal of clinical nutrition.
[39] J. Kaye,et al. Cognitive impairment risk , 2009, Neurology.
[40] H. Markus,et al. The Genetics of Cervical Artery Dissection: A Systematic Review , 2009, Stroke.
[41] Anders M. Dale,et al. MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: Reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths , 2009, NeuroImage.
[42] M. Weiner,et al. Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease* , 2009, Brain : a journal of neurology.
[43] B. Mazoyer,et al. Longitudinal follow-up of individual white matter hyperintensities in a large cohort of elderly , 2009, Neuroradiology.
[44] Lewis H Kuller,et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial. , 2008, JAMA.
[45] D. Mozaffarian,et al. Fish consumption and risk of subclinical brain abnormalities on MRI in older adults , 2008, Neurology.
[46] R Brookmeyer,et al. Prevalence of dementia after age 90 , 2008, Neurology.
[47] J. Kaye,et al. Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline , 2008, Neurology.
[48] J. Quinn,et al. Alzheimer's disease and the Blood-Brain Barrier: Past, Present and Future. , 2008, Aging health.
[49] P. Sachdev,et al. Ocular dipping and ping-pong gaze in hypoxic encephalopathy , 2007, Neurology.
[50] Thomas D. Parsons,et al. Timed Gait Test: Normative Data for the Assessment of the AIDS Dementia Complex , 2006, Journal of clinical and experimental neuropsychology.
[51] Lars-Olof Wahlund,et al. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. , 2006, Archives of neurology.
[52] L. H. Kuller,et al. Benefits of fatty fish on dementia risk are stronger for those without APOE ε4 , 2005, Neurology.
[53] M. Woodward,et al. Effects of Blood Pressure Lowering on Cerebral White Matter Hyperintensities in Patients With Stroke: The PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy , 2005, Circulation.
[54] A. Leaf,et al. Omega-3 fatty acids and ventricular arrhythmias. , 2005, World review of nutrition and dietetics.
[55] C. Enzinger,et al. Markers of Endothelial and Hemostatic Activation and Progression of Cerebral White Matter Hyperintensities: Longitudinal Results of the Austrian Stroke Prevention Study , 2005, Stroke.
[56] M. van Buchem,et al. Effect of pravastatin on cerebral infarcts and white matter lesions , 2005, Neurology.
[57] D. Harvey,et al. Measures of brain morphology and infarction in the framingham heart study: establishing what is normal , 2005, Neurobiology of Aging.
[58] D. Mozaffarian,et al. Fish consumption and stroke risk in elderly individuals: the cardiovascular health study. , 2005, Archives of internal medicine.
[59] A. Witkowska,et al. Soluble intercellular adhesion molecule-1 (sICAM-1): an overview. , 2004, European cytokine network.
[60] P. Sham,et al. Endothelial Nitric Oxide Gene Haplotypes and Risk of Cerebral Small-Vessel Disease , 2004, Stroke.
[61] T. Tombaugh. Trail Making Test A and B: normative data stratified by age and education. , 2004, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.
[62] Nicole A. Lazar,et al. Statistical Analysis With Missing Data , 2003, Technometrics.
[63] L. Kappelle,et al. Endothelial Cell Activation Is Associated with Cerebral White Matter Lesions in Patients with Cerebrovascular Disease , 2002, Annals of the New York Academy of Sciences.
[64] T. O. Meyer,et al. Observation of the decay Omega(0)(c)-->Omega(-)e(+)nu(e). , 2002, Physical review letters.
[65] J. Dietrich. The adhesion molecule ICAM-1 and its regulation in relation with the blood–brain barrier , 2002, Journal of Neuroimmunology.
[66] C. Jun,et al. Ultrastructure and Function of Dimeric, Soluble Intercellular Adhesion Molecule-1 (ICAM-1)* , 2001, The Journal of Biological Chemistry.
[67] C. Jun,et al. Dimerization and the effectiveness of ICAM-1 in mediating LFA-1-dependent adhesion , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[68] P. A. Peterson,et al. A key role for ICAM-1 in generating effector cells mediating inflammatory responses , 2001, Nature Immunology.
[69] J. Manson,et al. Intake of fish and omega-3 fatty acids and risk of stroke in women. , 2001, JAMA.
[70] R. Martins,et al. Insulin Effects on Glucose Metabolism, Memory, and Plasma Amyloid Precursor Protein in Alzheimer's Disease Differ According to Apolipoprotein‐E Genotype , 2000, Annals of the New York Academy of Sciences.
[71] H. Schouten,et al. Adaptive biased urn randomization in small strata when blinding is impossible. , 1995, Biometrics.
[72] N. Squires,et al. Construct validity in the Trail Making Test: what makes Part B harder? , 1995, Journal of clinical and experimental neuropsychology.
[73] J. Morris. The Clinical Dementia Rating (CDR) , 1993, Neurology.
[74] M. Folstein,et al. Population-based norms for the Mini-Mental State Examination by age and educational level. , 1993, JAMA.
[75] T. Salthouse. What do adult age differences in the Digit Symbol Substitution Test reflect? , 1992, Journal of gerontology.
[76] P. Paré,et al. Evidence for inflammation in asthma. , 1991, The American review of respiratory disease.
[77] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[78] W. J. Dyer,et al. A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.
[79] P. Zandi,et al. Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4. , 2005, Neurology.
[80] M. Sano,et al. An Inventory to Assess Activities of Daily Living for Clinical Trials in Alzheimer's Disease , 1997, Alzheimer disease and associated disorders.
[81] P A Parmelee,et al. Geriatric Depression Scale , 2002 .